Logo image of XONA.DE

EXXON MOBIL CORP (XONA.DE) Stock Fundamental Analysis

FRA:XONA - Deutsche Boerse Ag - US30231G1022 - Common Stock - Currency: EUR

93.9  -1.12 (-1.18%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to XONA. XONA was compared to 60 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and the financial health of XONA get a neutral evaluation. Nothing too spectacular is happening here. XONA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

XONA had positive earnings in the past year.
In the past year XONA had a positive cash flow from operations.
Of the past 5 years XONA 4 years were profitable.
In the past 5 years XONA always reported a positive cash flow from operatings.
XONA.DE Yearly Net Income VS EBIT VS OCF VS FCFXONA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B 60B

1.2 Ratios

XONA has a better Return On Assets (7.43%) than 65.00% of its industry peers.
Looking at the Return On Equity, with a value of 12.77%, XONA is in line with its industry, outperforming 50.00% of the companies in the same industry.
The Return On Invested Capital of XONA (8.12%) is comparable to the rest of the industry.
XONA had an Average Return On Invested Capital over the past 3 years of 11.97%. This is in line with the industry average of 11.93%.
Industry RankSector Rank
ROA 7.43%
ROE 12.77%
ROIC 8.12%
ROA(3y)10.7%
ROA(5y)6.43%
ROE(3y)19.64%
ROE(5y)11.66%
ROIC(3y)11.97%
ROIC(5y)N/A
XONA.DE Yearly ROA, ROE, ROICXONA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

XONA has a Profit Margin (9.93%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of XONA has grown nicely.
XONA has a worse Operating Margin (12.87%) than 61.67% of its industry peers.
In the last couple of years the Operating Margin of XONA has grown nicely.
XONA's Gross Margin of 29.53% is on the low side compared to the rest of the industry. XONA is outperformed by 70.00% of its industry peers.
XONA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.87%
PM (TTM) 9.93%
GM 29.53%
OM growth 3Y11.67%
OM growth 5Y16.33%
PM growth 3Y6.04%
PM growth 5Y12.09%
GM growth 3Y-1.5%
GM growth 5Y0.14%
XONA.DE Yearly Profit, Operating, Gross MarginsXONA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), XONA is creating some value.
XONA has more shares outstanding than it did 1 year ago.
XONA has more shares outstanding than it did 5 years ago.
XONA has a better debt/assets ratio than last year.
XONA.DE Yearly Shares OutstandingXONA.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
XONA.DE Yearly Total Debt VS Total AssetsXONA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100B 200B 300B 400B

2.2 Solvency

XONA has an Altman-Z score of 4.05. This indicates that XONA is financially healthy and has little risk of bankruptcy at the moment.
XONA's Altman-Z score of 4.05 is amongst the best of the industry. XONA outperforms 86.67% of its industry peers.
The Debt to FCF ratio of XONA is 1.36, which is an excellent value as it means it would take XONA, only 1.36 years of fcf income to pay off all of its debts.
XONA's Debt to FCF ratio of 1.36 is amongst the best of the industry. XONA outperforms 83.33% of its industry peers.
A Debt/Equity ratio of 0.14 indicates that XONA is not too dependend on debt financing.
XONA has a Debt to Equity ratio of 0.14. This is in the better half of the industry: XONA outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.36
Altman-Z 4.05
ROIC/WACC0.81
WACC10.02%
XONA.DE Yearly LT Debt VS Equity VS FCFXONA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50B 100B 150B 200B 250B

2.3 Liquidity

XONA has a Current Ratio of 1.31. This is a normal value and indicates that XONA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of XONA (1.31) is worse than 60.00% of its industry peers.
A Quick Ratio of 0.97 indicates that XONA may have some problems paying its short term obligations.
XONA's Quick ratio of 0.97 is on the low side compared to the rest of the industry. XONA is outperformed by 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.97
XONA.DE Yearly Current Assets VS Current LiabilitesXONA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

3

3. Growth

3.1 Past

XONA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.17%.
XONA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.13% yearly.
XONA shows a small growth in Revenue. In the last year, the Revenue has grown by 1.36%.
XONA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.83% yearly.
EPS 1Y (TTM)-18.17%
EPS 3Y13.13%
EPS 5Y26.13%
EPS Q2Q%-32.66%
Revenue 1Y (TTM)1.36%
Revenue growth 3Y7.03%
Revenue growth 5Y5.83%
Sales Q2Q%-1.09%

3.2 Future

XONA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.87% yearly.
The Revenue is expected to decrease by -6.52% on average over the next years.
EPS Next Y-11.59%
EPS Next 2Y3.8%
EPS Next 3Y9.22%
EPS Next 5Y9.87%
Revenue Next Year-4.58%
Revenue Next 2Y-1.57%
Revenue Next 3Y-0.97%
Revenue Next 5Y-6.52%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
XONA.DE Yearly Revenue VS EstimatesXONA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100B 200B 300B 400B
XONA.DE Yearly EPS VS EstimatesXONA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 5 10

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.71 indicates a correct valuation of XONA.
XONA's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 28.88, XONA is valued rather cheaply.
With a Price/Forward Earnings ratio of 15.51, XONA is valued correctly.
XONA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. XONA is more expensive than 65.00% of the companies in the same industry.
XONA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.20.
Industry RankSector Rank
PE 13.71
Fwd PE 15.51
XONA.DE Price Earnings VS Forward Price EarningsXONA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of XONA indicates a slightly more expensive valuation: XONA is more expensive than 66.67% of the companies listed in the same industry.
XONA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 15.04
EV/EBITDA 7.24
XONA.DE Per share dataXONA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2Y3.8%
EPS Next 3Y9.22%

4

5. Dividend

5.1 Amount

XONA has a Yearly Dividend Yield of 3.65%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 62.39, XONA is paying slightly less dividend.
XONA's Dividend Yield is a higher than the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 3.65%

5.2 History

The dividend of XONA has a limited annual growth rate of 3.02%.
Dividend Growth(5Y)3.02%
Div Incr Years6
Div Non Decr Years6
XONA.DE Yearly Dividends per shareXONA.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

XONA pays out 49.60% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of XONA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP49.6%
EPS Next 2Y3.8%
EPS Next 3Y9.22%
XONA.DE Yearly Income VS Free CF VS DividendXONA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B
XONA.DE Dividend Payout.XONA.DE Dividend Payout, showing the Payout Ratio.XONA.DE Dividend Payout.PayoutRetained Earnings

EXXON MOBIL CORP

FRA:XONA (4/30/2025, 7:00:00 PM)

93.9

-1.12 (-1.18%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)01-31 2025-01-31/bmo
Earnings (Next)05-02 2025-05-02/bmo
Inst Owners65.74%
Inst Owner ChangeN/A
Ins Owners0.07%
Ins Owner ChangeN/A
Market Cap406.14B
Analysts75.63
Price Target109.59 (16.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.65%
Yearly Dividend3.53
Dividend Growth(5Y)3.02%
DP49.6%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.57%
Min EPS beat(2)1.31%
Max EPS beat(2)5.83%
EPS beat(4)3
Avg EPS beat(4)1.61%
Min EPS beat(4)-6.24%
Max EPS beat(4)5.83%
EPS beat(8)5
Avg EPS beat(8)1.97%
EPS beat(12)8
Avg EPS beat(12)3.36%
EPS beat(16)12
Avg EPS beat(16)4.07%
Revenue beat(2)0
Avg Revenue beat(2)-4.89%
Min Revenue beat(2)-5.12%
Max Revenue beat(2)-4.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.88%
Min Revenue beat(4)-5.12%
Max Revenue beat(4)4.99%
Revenue beat(8)3
Avg Revenue beat(8)-2.32%
Revenue beat(12)3
Avg Revenue beat(12)-3.86%
Revenue beat(16)4
Avg Revenue beat(16)-4.16%
PT rev (1m)-12.18%
PT rev (3m)-13.71%
EPS NQ rev (1m)2.33%
EPS NQ rev (3m)-5.96%
EPS NY rev (1m)-7.38%
EPS NY rev (3m)-13.85%
Revenue NQ rev (1m)0.95%
Revenue NQ rev (3m)1.87%
Revenue NY rev (1m)-0.83%
Revenue NY rev (3m)2.11%
Valuation
Industry RankSector Rank
PE 13.71
Fwd PE 15.51
P/S 1.36
P/FCF 15.04
P/OCF 8.39
P/B 1.75
P/tB 1.75
EV/EBITDA 7.24
EPS(TTM)6.85
EY7.29%
EPS(NY)6.06
Fwd EY6.45%
FCF(TTM)6.24
FCFY6.65%
OCF(TTM)11.19
OCFY11.91%
SpS68.96
BVpS53.61
TBVpS53.61
PEG (NY)N/A
PEG (5Y)0.52
Profitability
Industry RankSector Rank
ROA 7.43%
ROE 12.77%
ROCE 11.4%
ROIC 8.12%
ROICexc 8.64%
ROICexgc 8.64%
OM 12.87%
PM (TTM) 9.93%
GM 29.53%
FCFM 9.05%
ROA(3y)10.7%
ROA(5y)6.43%
ROE(3y)19.64%
ROE(5y)11.66%
ROIC(3y)11.97%
ROIC(5y)N/A
ROICexc(3y)13.17%
ROICexc(5y)N/A
ROICexgc(3y)13.17%
ROICexgc(5y)N/A
ROCE(3y)16.83%
ROCE(5y)N/A
ROICexcg growth 3Y9.55%
ROICexcg growth 5Y19.81%
ROICexc growth 3Y9.55%
ROICexc growth 5Y19.81%
OM growth 3Y11.67%
OM growth 5Y16.33%
PM growth 3Y6.04%
PM growth 5Y12.09%
GM growth 3Y-1.5%
GM growth 5Y0.14%
F-Score5
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.36
Debt/EBITDA 0.55
Cap/Depr 103.69%
Cap/Sales 7.16%
Interest Coverage 22.99
Cash Conversion 81.98%
Profit Quality 91.2%
Current Ratio 1.31
Quick Ratio 0.97
Altman-Z 4.05
F-Score5
WACC10.02%
ROIC/WACC0.81
Cap/Depr(3y)101.52%
Cap/Depr(5y)80.15%
Cap/Sales(3y)6.11%
Cap/Sales(5y)6.47%
Profit Quality(3y)96.28%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.17%
EPS 3Y13.13%
EPS 5Y26.13%
EPS Q2Q%-32.66%
EPS Next Y-11.59%
EPS Next 2Y3.8%
EPS Next 3Y9.22%
EPS Next 5Y9.87%
Revenue 1Y (TTM)1.36%
Revenue growth 3Y7.03%
Revenue growth 5Y5.83%
Sales Q2Q%-1.09%
Revenue Next Year-4.58%
Revenue Next 2Y-1.57%
Revenue Next 3Y-0.97%
Revenue Next 5Y-6.52%
EBIT growth 1Y-7.56%
EBIT growth 3Y19.52%
EBIT growth 5Y23.11%
EBIT Next Year39.5%
EBIT Next 3Y17.96%
EBIT Next 5Y14.07%
FCF growth 1Y-8.17%
FCF growth 3Y-5.2%
FCF growth 5Y41.81%
OCF growth 1Y-0.63%
OCF growth 3Y4.56%
OCF growth 5Y13.11%